2024 |
Kura Oncology Inc
|
Lead Independent Director |
426.1 K |
41.8 % |
2024 |
Gossamer Bio Inc
|
Chairman of the Board, President and Chief Executi |
- |
- |
2023 |
Kura Oncology Inc
|
Lead Independent Director |
300.5 K |
-1.8 % |
2023 |
Gossamer Bio Inc
|
Chairman of the Board, President and Chief Executi |
- |
- |
2022 |
Mirati Therapeutics Inc
|
Chairman of the Board |
979.8 K |
- |
2022 |
Kura Oncology Inc
|
Lead Independent Director |
305.9 K |
-21.4 % |
2022 |
Gossamer Bio Inc
|
Chairman of the Board, President and Chief Executi |
- |
- |
2021 |
Kura Oncology Inc
|
Lead Independent Director |
389.1 K |
13.9 % |
2021 |
Gossamer Bio Inc
|
Chairman of the Board, President and Chief Executi |
- |
- |
2020 |
Kura Oncology Inc
|
Independent Director |
341.6 K |
54.3 % |
2020 |
Gossamer Bio Inc
|
Chairman of the Board, President and Chief Executi |
- |
- |
2019 |
Gossamer Bio Inc
|
Non-Executive Chairman of the Board |
1.3 M |
- |
2019 |
Kura Oncology Inc
|
Independent Director |
221.3 K |
13.8 % |
2019 |
Immunic Inc
|
Chairman of the Board |
- |
- |
2018 |
Immunic Inc
|
Chairman of the Board |
235.3 K |
22.3 % |
2018 |
Kura Oncology Inc
|
Independent Director |
194.5 K |
78.9 % |
2018 |
Gossamer Bio Inc
|
Executive Chairman of the Board |
- |
- |
2017 |
Immunic Inc
|
Chairman of the Board |
192.4 K |
-28.2 % |
2017 |
Kura Oncology Inc
|
Independent Director |
108.7 K |
49.6 % |
2016 |
Immunic Inc
|
Independent Director |
267.9 K |
- |
2016 |
Kura Oncology Inc
|
Independent Director |
72.6 K |
-53.2 % |
2015 |
Kura Oncology Inc
|
Independent Director |
155.1 K |
- |
2014 |
Kura Oncology Inc
|
Independent Director |
- |
- |